Ἦθος ἀνθρώπῳ δαίμων–ethos anthropoi daimon—is a famous aphorism of the Greek philosopher Heraclitus (544–483 BC). While its deeper meaning is probably more complex, the conventional translation is “a human being's character is his/her fate.” When I was asked by George Billman to contribute my thoughts on the future of mitochondrial research it occurred to me that perhaps I could try to foretell the fate of mitochondrial research from its character, i.e., from the key themes from which the discipline developed. I will limit this brief comment to a few topics that also reflect my own interests, and that should not be considered even an attempt to be exhaustive. In the twentieth century the key issue in Bioenergetics (hence in mitochondrial research) has been the mechanism of energy conservation. The turning point was the proposal and then the demonstration of Peter Mitchell's chemiosmotic hypothesis, i.e., that in mitochondria the basic events are the coupling of aerobic electron transfer to H+ pumping, the formation of the H+ electrochemical gradient and its harnessing by the ATP synthase (Mitchell, 1966), reprinted in Mitchell (2011). It is remarkable that the most recent advances in structural biology and superresolution microscopy, which are removing hurdles and moving the boundaries of Science beyond imagination, have confirmed the basic tenets of chemiosmotic principles in amazing detail.
ATP Synthase
One example of how structural biology complemented physiology is the solution to the question of the H+/ATP stoichiometry, which had been the matter of considerable discussion (Brand and Lehninger, 1977; Sholtz et al., 1983). The demonstration that different organisms possess c rings (the rotating barrel powered by H+ flux) with a number of subunits varying between a minimum of 8 and a maximum of 17, and the fact that one full rotation cycle generates 3 ATP molecules (Boyer, 1997) has both defined the precise stoichiometry for each type of c ring (between 2.67 and 5.67 H+/ATP) and explained the apparent variability in the stoichiometry itself, see Nirody et al. (2020) for a review. While the basic structure and catalytic mechanism of ATP synthases is highly conserved across species, what is most puzzling is the existence of profound differences in the non-catalytic parts of the enzyme, which evolved to include a numer of subunits that were indeed defined “supernumerary” (Vaillier et al., 1999) because they are not essential for the catalytic activity. These subunits are involved in the process of dimerization and of membrane bending that contributes to generate the inner membrane cristae, which are then stabilized by the lateral association of dimers (Paumard et al., 2002; Dudkina et al., 2006; Jiko et al., 2015; Kühlbrandt, 2019; Spikes et al., 2021). And yet, clear species-specific differences exist in primary structure of these subunits, suggesting that they may serve additional function(s) that have not been fully discovered yet (Kühlbrandt, 2019). I think that research on the physiological function(s) of “supernumerary” subunits of ATP synthases (which may include the controversial formation of the high-conductance permeability transition pore) (Giorgio et al., 2013; Alavian et al., 2014; He et al., 2017a,b; Carroll et al., 2019; Mnatsakanyan et al., 2019; Urbani et al., 2019; Pinke et al., 2020) will be a very fruitful field of investigation in the years to come.
A Supercomplex Matter
High-resolution definition of individual mitochondrial respiratory complexes, which begun over 20 years ago, has also yielded key information on the mechanisms of proton translocation coupled to electron transfer (Tsukihara et al., 1996; Xia et al., 1997; Michel et al., 1998; Baradaran et al., 2013; Zickermann et al., 2015; Kampjut and Sazanov, 2020). How electrons are transferred between respiratory complexes and whether this requires stable interactions is a question of great relevance, that to the best of my knowledge was clearly posed and addressed with inhibitor titration studies by Stoner (1984). The existence of respiratory supercomplexes made by associations of complexes I, III, and IV with defined stoichiometries in the native membrane is now established, and the role of supercomplexes in pathophysiology is increasingly appreciated (Schägger and Pfeiffer, 2000, 2001; Bianchi et al., 2004; Acín-Pérez et al., 2008; Dudkina et al., 2011; Lapuente-Brun et al., 2013; Letts et al., 2016; Milenkovic et al., 2017; Rathore et al., 2019; Berndtsson et al., 2020; Protasoni et al., 2020). An important question is the role of the supercomplex assembly factor SCAF1, which has been shown to promote supercomplex formation between CIII and IV (III2IV) and contribute to “branching” of the respiratory chain (Calvo et al., 2020). This topic is generating a very lively discussion that is likely to continue in the future (Mourier et al., 2014; Enríquez, 2016; Milenkovic et al., 2017; Lobo-Jarne et al., 2018; García-Poyatos et al., 2020; Protasoni et al., 2020; Fernández-Vizarra et al., 2021).
DE(Localized) Gradients?
Another interesting question is whether H+ pumping (together with the low permeability of the inner membrane) can generate a delocalized electric field rapidly spreading to the whole network (Amchenkova et al., 1988), or rather mitochondria should be seen as a mosaic of localized coupling units where the H+ pumping complexes and ATP synthases are closely spaced to make individual functional units without the need for lateral diffusion of charges (Yaguzhinsky et al., 2006), two hypotheses that may actually not be mutually exclusive (Westerhoff et al., 1986). Recent work using high resolution microscopy has demonstrated that both have merit and that, to some extent, the issue may be a matter of definition (i.e., what is meant by “short” and “long” range) and possibly of anatomy. Long range diffusion may predominate in tissues were mitochondria are mostly in the form of tubular, continuous structures (like in muscle) (Glancy et al., 2015) while local coupling (with formation of individual disc-shaped crista structures) may prevail where (or when) mitochondria are in the form of individual organelles (Wolf et al., 2019). This area of research has also made great progress on the fusion-fission events that regulate mitochondrial morphology and function (Giacomello et al., 2020). I think that superresolution microscopy together with the genetic manipulation of determinants of mitochondrial morphology will allow further definition of subcellular electrical events that bear both on mitochondrial function and on the shaping of localized ion gradients.
Mitochondrial Dynamics
Mitochondrial dynamics is a topic of enormous interest and of great additional potential in spite of the major progress made in recent years. The pioneering work of Jürgen Bereiter-Hahn provided a detailed description of mitochondrial motion and of fusion-fission events in vivo (Bereiter-Hahn, 1990; Bereiter-Hahn and Voth, 1994). The molecular basis for mitochondrial dynamics is being unraveled at a steady pace, and is revealing the delicate balance between proteins that favor mitochondrial fusion and those that promote mitochondrial fission, their relationships with the cell cycle and with mitochondrial responses to pathophysiological perturbations (which depend on the cell type as much as on the stimulus), their role in cell survival and death, and their relationship to proteins that determine the maintenance of mitochondrial ultrastructure and its close interactions with the endoplasmic reticulum (Osteryoung and Nunnari, 2003; Mishra and Chan, 2016; Eisner et al., 2018; Giacomello et al., 2020).
Cation Channels
When thinking of mitochondria and subcellular, localized ion gradients one obviously thinks of Ca2+ (Rizzuto et al., 1993) and this takes us to one of the paradoxes that accompanied the progressive acceptance of the chemiosmotic hypothesis. The existence of a proton electrochemical gradient as the energetic intermediate between respiration and ATP synthesis poses some constraints on membrane permeability to cations. Indeed, it was noted that equilibrium distribution of K+ and Ca2+ across a membrane maintaining an electrical potential difference of 180 mV (negative inside) would have meant matrix concentrations of about 150 M for K+ and 1 M for Ca2+, see Bernardi (1999) for a detailed review. Mitchell was aware of this problem and conceived two complementary postulates to solve it. The first (3rd postulate of chemiosmosis) is that the inner membrane possesses electroneutral H+-cation exchangers allowing extrusion of cations entering the matrix down their electrochemical gradient. Operation of the exchangers (Mitchell and Moyle, 1969; Garlid, 1978, 1979) prevents the otherwise inevitable accumulation of cations that would lead to swelling and osmotic lysis of the organelle. The quest for the K+-H+ exchanger is still under way, although the LETM1 protein is clearly involved in mitochondrial cation homeostasis through modulation of the K+-H+ exchange process (Nowikovsky et al., 2004, 2007) and possibly also of electroneutral Ca2+-H+ exchange (Tsai et al., 2014), an issue that is still the matter of discussion (De Marchi et al., 2014; Nowikovsky and Bernardi, 2014), see Austin and Nowikovsky (2019) for a recent review. The second (4th postulate of chemiosmosis) is that the inner membrane has a low permeability to protons and to anions and cations generally (Mitchell, 1966, 2011). The latter point was almost universally (and as it turns out, erroneously) taken to mean that mitochondria could not possess channels for cations, a point that pervaded the literature well until the turn of last century (Garlid et al., 1989). This state of affairs considerably delayed the discovery of the mitochondrial Ca2+ uniporter (MCU) and its regulatory subunits (Perocchi et al., 2010; Baughman et al., 2011; De Stefani et al., 2011; Mallilankaraman et al., 2012; Sancak et al., 2013; Kamer and Mootha, 2014; Mammucari et al., 2016) and the assessment of their role in disease (Logan et al., 2014; Debattisti et al., 2019); and of mitochondrial K+ channels (Inoue et al., 1991; Szewczyk et al., 2006; Szabó and Zoratti, 2014; Paggio et al., 2019). The great wave coming from these areas of research is unlikely to subside, and will translate in more breakthroughs on how mitochondrial participate and contribute to the shaping of intracellular ion gradients.
Inner Membrane Permeability and Pathophysiology
As the chemiosmotic hypothesis became consolidated, a set of early observations on the Ca2+-dependent permeability increase to ions and solutes through “permeability defects” with a pore radius of 14 Å (Massari and Azzone, 1972) became widely interpreted as an in vitro artifact of little relevance to mitochondrial physiology, see Bernardi et al. (2006) for a specific review. Only a few Authors interpreted the increased permeability (defined permeability transition, PT, by Haworth and Hunter) as a potentially regulated event serving a role in pathophysiology (Haworth and Hunter, 1979; Hunter and Haworth, 1979a,b; Pfeiffer et al., 1979; Crompton et al., 1987), possibly as a regulated pathway for Ca2+ release (Bernardi and Petronilli, 1996), which is consistent with a number of observations (Carraro et al., 2020). While today there is a general agreement that the PT is mediated by opening of a channel, its molecular identity is the matter of discussion. The latest results suggest that the PT can be mediated by a Ca2+-dependent conformational change of both the adenine nucleotide translocator (ANT) and the ATP synthase, through mechanisms that still need to be defined, see Carraro et al. (2020) for a discussion. The PT has been shown to play a role in necrotic cell death in a set of studies (Duchen et al., 1993; Imberti et al., 1993; Pastorino et al., 1993) that were greatly helped by the demonstration that the PT is inhibited by cyclosporin A (Fournier et al., 1987; Crompton et al., 1988; Broekemeier et al., 1989) through the matrix protein cyclophilin D (Halestrap and Davidson, 1990; Nicolli et al., 1996). The PT was then shown to play a role in apoptosis as well (Marchetti et al., 1996). Together with the discovery that cytochrome c release from the intermembrane space triggers the mitochondrial pathway of apoptosis through activation of procaspase 9 (Liu et al., 1996), these studies opened a new season in mitochondrial research that is lasting to this day for its major implications in the pathogenesis of both degenerative diseases and cancer. Selective cytochome c release can be achieved by Bax/Bak-dependent permeabilization of the outer mitochondrial membrane following insertion of tBid generated by activation of caspase 8 (Wei et al., 2000) in a process that is substantially opposed by the antiapoptotic protein Bcl-2 (Susin et al., 1996; Yang et al., 1997). Release of cytochrome c can also be a consequence of PTP-dependent swelling (Petronilli et al., 1994) and/or cristae remodeling (Scorrano et al., 2002), and there is an intriguing promoting effect of Bax/Bak (Karch et al., 2013) and an inhibitory effect of Bcl-2 on onset of the PT (Susin et al., 1996). The latter is contrasted by Bcl-2 small molecule interactors (Milanesi et al., 2006) able to reactivate the mitochondrial death program (Oltersdorf et al., 2005) and these regulatory events extend to a variety of Bcl-2 family members (Singh et al., 2019). In a striking therapeutic development, the Bcl-2 ligand ABT-199 (venetoclax) has been introduced in the treatment of a variety of hematologic malignancies (Souers et al., 2013; de Ridder et al., 2021). It should also be mentioned that mitochondria play a key role in degenerative diseases, particularly muscular dystrophies and neurodegenerative conditions ranging from Parkinson's to Alzheimer diseases, amyotrophic lateral sclerosis, multiple sclerosis; and in organ ischemia-reperfusion injury. The mechanisms and targets, which include the PT, are so many that I will not even try to list them, but I would like to mention early work that anticipated these modern developments of mitochondrial pathophysiology (Hunter and Ford, 1955; Kasbekar and Sreenivasan, 1956; Hoch, 1962; Luft et al., 1962; Wollenberger et al., 1963; van Wijngaardeen et al., 1967; Sternlieb, 1968; Jennings et al., 1969; Fleckenstein et al., 1974; Wrogemann and Pena, 1976; Singer et al., 1987), see Bernardi et al. (2015) for relevant literature.
Adenine Nucleotide Translocator and Uncoupling Proteins
Another historical area of research where breakthroughs are being made is that of nucleotide transport via the ANT. It had long been proposed that the overall exchange of ADP for ATP was mediated by a single substrate-binding site alternately accessible from either side of the membrane (Klingenberg, 1979; Ruprecht et al., 2014). The most recent structures fully confirm this single-pore gating mechanism, whereby in energized mitochondria the nucleotide exchange reaction is mediated by unidirectional uptake of ADP and efflux of ATP “taking turns” on the carrier (Ruprecht et al., 2019). Many issues still await an answer, however. It has recently been shown that in the presence of arachidonic, palmitic or lauric acid the ANT can also transfer H+ in mitochondria that do not express uncoupling protein 1 (UCP1) (Bertholet et al., 2019), the bona fide H+ channel that mediates non-shivering thermogenesis in brown fat (Nicholls, 1976; Rafael and Heldt, 1976). The existence of ANT-mediated H+ currents detected in patch-clamp experiments (Bertholet et al., 2019) supports the earlier suggestion that the ANT mediates a sizeable fraction of the “H+ leaks” responsible for basal respiration (Andreyev et al., 1988; Brustovetsky and Klingenberg, 1994). ANT and UCP1 are closely related proteins and both require long-chain fatty acids for H+ translocation and yet the molecular mechanisms appears to differ, as only in UCP1 the fatty acid anion participates in the actual mechanism of H+ transport (Fedorenko et al., 2012) while it plays a cofactor role in ANT (Bertholet et al., 2019), see Bernardi (2019) for a summary. It will be interesting to test whether other members of the SLC25 superfamily of mitochondrial solute carriers (Palmieri and Monné, 2016) can mediate the occurrence of H+ leaks. An additional open question about the ANT is how it can be transformed by Ca2+ in a high-conductance channel stimulated by cyclophilin D with an effect prevented by the cognate inhibitor of the latter cyclosporin A (Brustovetsky and Klingenberg, 1996; Brustovetsky et al., 2002), see Carraro et al. (2020) for a recent discussion.
Mitochondrial DNA
Mitochondria possess their own DNA and translation machinery. Diseases of mtDNA have first been described not so long ago (Wallace et al., 1988), and a new frontier is the manipulation of mtDNA, which holds great promise for a future correction of mtDNA diseases (Gammage et al., 2018) and possibly to treat cancer (Bonekamp et al., 2020). It is remarkable that only 13 out of the roughly 1,100 proteins found in mitochondria are encoded by mtDNA (Rath et al., 2020). During evolution mtDNA has retained only a core set of genes of the respiratory chain and F-ATP synthase, possibly to permit rapid adaptation to changing environments (Wallace, 2007). How mitochondrial and nuclear genomes integrate in mitochondrial biogenesis remains a fascinating topic (Becker et al., 2019) as is the somewhat specular issue of how cells exploit mitochondrial “diversity” by releasing into the circulation mitochondrial damage-associated molecular patterns (including mtDNA) to engage toll-like receptors and innate immune pathways (Zhang et al., 2010; Shintani et al., 2014; Rodríguez-Nuevo et al., 2018) and activate inflammation (Zhou et al., 2011; Oka et al., 2012; Zhong et al., 2018). This is strikingly similar to the effect of microbial pathogen-associated molecular patterns and provides an exciting link to STING, which regulates the type I interferon response (Sliter et al., 2018). The mechanism for mtDNA release is an interesting issue on its own, because it could be a regulated process mediated by the permeability transition pore (Yu et al., 2020) rather than the unspecific result of cell damage, an issue that will certainly attract more attention.
An Unexpected Twist on Hypoxia
The discovery that mitochondria are involved in the HIF-mediated response to hypoxia (Samanta and Semenza, 2018) through succinate-dependent stabilization of HIF-1α (Selak et al., 2005) and modulation of expression of cytochrome oxidase subunits (Fukuda et al., 2007) was a turning point for our understanding of metabolic adaptation of tumors, first proposed as a causative event in cancer by Otto Warburg (Warburg et al., 1927; Warburg, 1956). A further mechanistic link was provided by the demonstration that TRAP1, a protein targeted to mitochondria in many tumors, inhibits succinate dehydrogenase and leads to succinate accumulation, stabilizing HIF-1α under normoxic conditions and thus making tumor cells ready to resist the impending onset of hypoxia (Sciacovelli et al., 2013). The unexpected twist is that hypoxia has a beneficial effect in disorders of the respiratory chain through activation of an endogenous program that allows adaptation. Chronic hypoxia led to a marked improvement in survival and vital parameters in a mouse model of Leigh syndrome, an effect that could not be explained by activation of the HIF transcriptional program (Jain et al., 2016). Rather, mice underwent an age-dependent decline in overall oxygen consumption with brain hyperoxia, which was normalized by hypoxic breathing, carbon monoxide or severe anemia with matching reversal of the neurological disease (Jain et al., 2019). These exciting new results suggest that unused oxygen rather than hypoxia itself may be the culprit, and open up new perspectives to normalize brain tissue hyperoxia (Jain et al., 2019). Genome-wide CRISPR screens at low oxygen tension have now identified genes with relative fitness defects in high or low oxygen, and most of these did not have an obvious connection to HIF (Jain et al., 2020). Remarkably, knockouts of mitochondrial pathways that are presumed to be essential, including complex I, grew relatively well at low oxygen (Jain et al., 2020). This approach is leading to the discovery of hundreds of genes linked to oxygen homeostasis, and there is more. Hypoxia has recently been shown to induce matrix acidification with release of Ca2+ from calcium phosphate precipitates, increased free [Ca2+] and matrix influx of Na+ on the Na+/Ca2+ exchanger (Hernansanz-Agustín et al., 2020). Na+ interaction with phospholipids then reduced inner membrane fluidity, selectively decreasing mobility of free ubiquinone between complex II and III but not inside supercomplexes, thus leading to increased superoxide production at complex III, a novel control mechanism of redox signaling that may have profound consequences for cellular metabolism (Hernansanz-Agustín et al., 2020).
Intraorganelle Buffering
Another topic that I find particularly fascinating is intramitochondrial communication between the two “arms” of oxidative phosphorylation, i.e., the respiratory chain and the ATP synthase. Respiratory complex III is assembled from a core containing cytochrome b (the only component encoded by mtDNA) and subunits Qcr7 and Qcr8, followed by the incorporation of all other subunits (Smith et al., 2012). As is the case with other respiratory complexes, specific proteins are required for the assembly of complex III including Bcs1 (Nobrega et al., 1992), an assembly factor that is the most frequent target of mutations in human complex III-related diseases. Extragenic compensatory mutations of yeast bcs1 have been identified that preferentially target the ATP synthase complex, leading to selective decrease of its ATP hydrolytic activity with substantial preservation of ATP synthesis (Ostojic et al., 2013). Thus, the bioenergetics consequences of respiratory impairment appear to be limited by minimizing the hydrolysis of ATP. These results have recently been extended in a thorough study of the Mootha laboratory, who have found that the cellular defects derived from chemical inhibition of complex V with oligomycin are suppressed by loss of complex I activity induced by both genetic and pharmacological means (To et al., 2019). This is a striking example of “intra-organelle” buffering that was also seen for a variety of other mitochondrial inhibitors, suggesting that certain forms of mitochondrial dysfunction may be buffered with “second site” inhibition within the organelle (To et al., 2019). Consistent with the existence of a regulatory feedback between biogenesis of respiratory complexes and of the ATP synthase, ablation of specific subunits of ATP synthase (that largely prevented its assembly) caused a striking decrease of electron transfer chain complexes, with reduction of respiration to negligible rates (He et al., 2017a,b; Carroll et al., 2019).
Not All Could be Predicted
The more I tried to cover new perspectives that are rooted in the history of mitochondrial research, the more I realized that my selective account was inevitably leaving out a number exciting developments. I will mention the relationships of autophagy with mitochondrial fission-fusion events (Twig et al., 2008; Lazarou et al., 2015; Dorn, 2016); the role of mitochondria in the antiviral response (Kozaki et al., 2017), in the growth of intracellular parasites (Pernas et al., 2018), in antigen presentation (Matheoud et al., 2016), in T cell function (Okoye et al., 2015; Weinberg et al., 2019) and dysfunction (Desdin-Mico et al., 2020), in metabolic reprogramming of macrophages (Mills et al., 2016; Acín-Pérez et al., 2020), in angiogenesis (Herkenne et al., 2020), in systemic stress response mediated by FGF21 (Forsstrom et al., 2019), in non-alcoholic steatohepatitis, where downregulation of mitochondrial circular RNA prevents inhibition of the permeability transition pore by the SCAR protein (Zhao et al., 2020); recent advances on the mechanism of germline selection of human mtDNA (Wei et al., 2019); and the most unexpected finding that the protein product of the ARHGAP11B gene, which plays an essential role in development of the human neocortex (Heide et al., 2020), localizes to mitochondria to inhibit the permeability transition pore (Namba et al., 2020). It is reassuring, indeed, that not all could be predicted.
Statements
Author contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Funding
Research in my laboratory was supported by Associazione Italiana Ricerca sul Cancro (IG17067), Fondation Leducq (16CVD04), the Italian Ministry for University and Research (2017LHFW42) and Telethon (GGP17092).
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Acín-PérezR.Fernández-SilvaP.PeleatoM. L.Pérez-MartosA.EnriquezJ. A. (2008). Respiratory active mitochondrial supercomplexes. Mol. Cell32, 529–539. 10.1016/j.molcel.2008.10.021
2
Acín-PérezR.IborraS.Martí-MateosY.CookE. C. L.Conde-GarrosaR.PetcherskiA.et al. (2020). Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity. Nat. Metab.2, 974–988. 10.1038/s42255-020-00273-8
3
AlavianK. N.BeutnerG.LazroveE.SacchettiS.ParkH. A.LicznerskiP.et al. (2014). An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc. Natl. Acad. Sci. U.S.A.111, 10580–10585. 10.1073/pnas.1401591111
4
AmchenkovaA. A.BakeevaL. E.ChentsovY. S.SkulachevV. P.ZorovD. B. (1988). Coupling membranes as energy-transmitting cables. I. Filamentous mitochondria in fibroblasts and mitochondrial clusters in cardiomyocytes. J. Cell Biol.107, 481–495. 10.1083/jcb.107.2.481
5
AndreyevA. Y.BondarevaT. O.DedukhovaV. I.MokhovaE. N.SkulachevV. P.VolkovN. I. (1988). Carboxyatractylate inhibits the uncoupling effect of free fatty acids. FEBS Lett.226, 265–269. 10.1016/0014-5793(88)81436-4
6
AustinS.NowikovskyK. (2019). LETM1: Essential for Mitochondrial Biology and Cation Homeostasis?Trends Biochem. Sci.44, 648–658. 10.1016/j.tibs.2019.04.002
7
BaradaranR.BerrisfordJ. M.MinhasG. S.SazanovL. A. (2013). Crystal structure of the entire respiratory complex I. Nature494, 443–448. 10.1038/nature11871
8
BaughmanJ. M.PerocchiF.GirgisH. S.PlovanichM.Belcher-TimmeC. A.SancakY.et al. (2011). Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature476, 341–345. 10.1038/nature10234
9
BeckerT.SongJ.PfannerN. (2019). Versatility of preprotein transfer from the cytosol to mitochondria. Trends Cell. Biol.29, 534–548. 10.1016/j.tcb.2019.03.007
10
Bereiter-HahnJ. (1990). Behavior of mitochondria in the living cell. Int. Rev. Cytol.122, 1–63. 10.1016/S0074-7696(08)61205-X
11
Bereiter-HahnJ.VothM. (1994). Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc. Res. Tech.27, 198–219. 10.1002/jemt.1070270303
12
BernardiP. (1999). Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev.79, 1127–1155. 10.1152/physrev.1999.79.4.1127
13
BernardiP. (2019). Mitochondrial H+ permeability through the ADP/ATP carrier. Nat. Metab.1, 752–753. 10.1038/s42255-019-0079-y
14
BernardiP.KrauskopfA.BassoE.PetronilliV.Blachly-DysonE.Di LisaF.et al. (2006). The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J.273, 2077–2099. 10.1111/j.1742-4658.2006.05213.x
15
BernardiP.PetronilliV. (1996). The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr.28, 131–138. 10.1007/BF02110643
16
BernardiP.RasolaA.ForteM.LippeG. (2015). The mitochondrial permeability transition pore: channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology. Physiol. Rev.95, 1111–1155. 10.1152/physrev.00001.2015
17
BerndtssonJ.AufschnaiterA.RathoreS.Marin-BueraL.DawitzH.DiesslJ.et al. (2020). Respiratory supercomplexes enhance electron transport by decreasing cytochrome c diffusion distance. EMBO Rep.21, e51015. 10.15252/embr.202051015
18
BertholetA. M.ChouchaniE. T.KazakL.AngelinA.FedorenkoA.LongJ. Z.et al. (2019). H+ transport is an integral function of the mitochondrial ADP/ATP carrier. Nature571, 515–520. 10.1038/s41586-019-1400-3
19
BianchiC.GenovaM. L.Parenti CastelliG.LenazG. (2004). The mitochondrial respiratory chain is partially organized in a supercomplex assembly: kinetic evidence using flux control analysis. J. Biol. Chem.279, 36562–36569. 10.1074/jbc.M405135200
20
BonekampN. A.PeterB.HillenH. S.FelserA.BergbredeT.ChoidasA.et al. (2020). Small-molecule inhibitors of human mitochondrial DNA transcription. Nature588, 712–716. 10.1038/s41586-020-03048-z
21
BoyerP. D. (1997). The ATP synthase–a splendid molecular machine. Annu. Rev. Biochem.66, 717–749. 10.1146/annurev.biochem.66.1.717
22
BrandM. D.LehningerA. L. (1977). H+/ATP ratio during ATP hydrolysis by mitochondria: modification of the chemiosmotic theory. Proc. Natl. Acad. Sci. U.S.A.74, 1955–1959. 10.1073/pnas.74.5.1955
23
BroekemeierK. M.DempseyM. E.PfeifferD. R. (1989). Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem.264, 7826–7830. 10.1016/S0021-9258(18)83116-7
24
BrustovetskyN.KlingenbergM. (1994). The reconstituted ADP/ATP carrier can mediate H+ transport by free fatty acids, which is further stimulated by mersalyl. J. Biol. Chem.269, 27329–27336. 10.1016/S0021-9258(18)46989-X
25
BrustovetskyN.KlingenbergM. (1996). Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry35, 8483–8488. 10.1021/bi960833v
26
BrustovetskyN.TropschugM.HeimpelS.HeidkamperD.KlingenbergM. (2002). A large Ca2+-dependent channel formed by recombinant ADP/ATP carrier from Neurospora crassa resembles the mitochondrial permeability transition pore. Biochemistry41, 11804–11811. 10.1021/bi0200110
27
CalvoE.CogliatiS.Hernansanz-AgustínP.Loureiro-LopezM.GuarasA.CasusoR. A.et al. (2020). Functional role of respiratory supercomplexes in mice: SCAF1 relevance and segmentation of the Qpool. Sci. Adv.6:eaba7509. 10.1126/sciadv.aba7509
28
CarraroM.CarrerA.UrbaniA.BernardiP. (2020). Molecular nature and regulation of the mitochondrial permeability transition pore(s), drug target(s) in cardioprotection. J. Mol. Cell. Cardiol.144, 76–86. 10.1016/j.yjmcc.2020.05.014
29
CarrollJ.HeJ.DingS.FearnleyI. M.WalkerJ. E. (2019). Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase. Proc. Natl Acad. Sci. U.S.A.116, 12816–12821. 10.1073/pnas.1904005116
30
CromptonM.CostiA.HayatL. (1987). Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem. J.245, 915–918. 10.1042/bj2450915
31
CromptonM.EllingerH.CostiA. (1988). Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J.255, 357–360.
32
De MarchiU.Santo-DomingoJ.CastelbouC.SeklerI.WiederkehrA.DemaurexN. (2014). NCLX protein, but not LETM1, mediates mitochondrial Ca2+ extrusion, thereby limiting Ca2+-induced NAD(P)H production and modulating matrix redox state. J. Biol. Chem.289, 20377–20385. 10.1074/jbc.M113.540898
33
de RidderI.KerkhofsM.VeettilS. P.DehaenW.BultynckG. (2021). Cancer cell death strategies by targeting Bcl-2's BH4 domain. Biochim. Biophys. Acta Mol. Cell Res.1868:118983. 10.1016/j.bbamcr.2021.118983
34
De StefaniD.RaffaelloA.TeardoE.SzabóI.RizzutoR. (2011). A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature476, 336–118340. 10.1038/nature10230
35
DebattistiV.HornA.SinghR.SeifertE. L.HogarthM. W.MazalaD. A.et al. (2019). Dysregulation of mitochondrial Ca2+ uptake and sarcolemma repair underlie muscle weakness and wasting in patients and mice lacking MICU1. Cell Rep.29, 1274–1286. 10.1016/j.celrep.2019.09.063
36
Desdin-MicoG.Soto-HerederoG.ArandaJ. F.OllerJ.CarrascoE.Gabande-RodriguezE.et al. (2020). T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science368, 1371–1376. 10.1126/science.aax0860
37
DornG. W. (2016). Central parkin: the evolving role of parkin in the heart. Biochim. Biophys. Acta1857, 1307–1312. 10.1016/j.bbabio.2016.03.014
38
DuchenM. R.McGuinnessO.BrownL. A.CromptonM. (1993). On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res.27, 1790–1794. 10.1093/cvr/27.10.1790
39
DudkinaN. V.KudryashevM.StahlbergH.BoekemaE. J. (2011). Interaction of complexes I, III, and IV within the bovine respirasome by single particle cryoelectron tomography. Proc. Natl. Acad. Sci. U.S.A.108, 15196–15200. 10.1073/pnas.1107819108
40
DudkinaN. V.SunderhausS.BraunH. P.BoekemaE. J. (2006). Characterization of dimeric ATP synthase and cristae membrane ultrastructure from Saccharomyces and Polytomella mitochondria. FEBS Lett.580, 3427–3432. 10.1016/j.febslet.2006.04.097
41
EisnerV.PicardM.HajnóczkyG. (2018). Mitochondrial dynamics in adaptive and maladaptive cellular stress responses. Nat. Cell Biol.20, 755–765. 10.1038/s41556-018-0133-0
42
EnríquezJ. A. (2016). Supramolecular organization of respiratory complexes. Annu. Rev. Physiol.78, 533–561. 10.1146/annurev-physiol-021115-105031
43
FedorenkoA.LishkoP. V.KirichokY. (2012). Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell151, 400–413. 10.1016/j.cell.2012.09.010
44
Fernández-VizarraE.López-CalcerradaS.FormosaL. E.Pérez-PérezR.DingS.FearnleyI. M.et al. (2021). SILAC-based complexome profiling dissects the structural organization of the human respiratory supercomplexes in SCAFIKO cells. Biochim. Biophys. Acta1862:148414. 10.1016/j.bbabio.2021.148414
45
FleckensteinA.JankeJ.DoringH. J.LederO. (1974). Myocardial fiber necrosis due to intracellular Ca overload-a new principle in cardiac pathophysiology. Recent Adv. Stud. Cardiac. Struct. Metab.4, 563–580.
46
ForsstromS.JacksonC. B.CarrollC. J.KuronenM.PirinenE.PradhanS.et al. (2019). Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions. Cell Metab.30, 1040–1054. 10.1016/j.cmet.2019.08.019
47
FournierN.DucetG.CrevatA. (1987). Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr.19, 297–303. 10.1007/BF00762419
48
FukudaR.ZhangH.KimJ. W.ShimodaL.DangC. V.SemenzaG. L. (2007). HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell129, 111–122. 10.1016/j.cell.2007.01.047
49
GammageP. A.MoraesC. T.MinczukM. (2018). Mitochondrial genome engineering: the revolution may not be CRISPR-Ized. Trends Genet.34, 101–110. 10.1016/j.tig.2017.11.001
50
García-PoyatosC.CogliatiS.CalvoE.Hernansanz-AgustínP.LagarrigueS.MagniR.et al. (2020). Scaf1 promotes respiratory supercomplexes and metabolic efficiency in zebrafish. EMBO Rep.21:e50287. 10.15252/embr.202050287
51
GarlidK. D. (1978). Unmasking the mitochondrial K/H exchanger: swelling-induced K+-loss. Biochem. Biophys. Res. Commun.83, 1450–1455. 10.1016/0006-291X(78)91383-9
52
GarlidK. D. (1979). Unmasking the mitochondrial K/H exchanger: tetraethylammonium-induced K+-loss. Biochem. Biophys. Res. Commun.87, 842–847. 10.1016/0006-291X(79)92034-5
53
GarlidK. D.BeavisA. D.RatkjeS. K. (1989). On the nature of ion leaks in energy-transducing membranes. Biochim. Biophys. Acta976, 109–120. 10.1016/S0005-2728(89)80219-1
54
GiacomelloM.PyakurelA.GlytsouC.ScorranoL. (2020). The cell biology of mitochondrial membrane dynamics. Nat. Rev. Mol. Cell Biol.21, 204–224. 10.1038/s41580-020-0210-7
55
GiorgioV.von StockumS.AntonielM.FabbroA.FogolariF.ForteM.et al. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. U.S.A.110, 5887–5892. 10.1073/pnas.1217823110
56
GlancyB.HartnellL. M.MalideD.YuZ. X.CombsC. A.ConnellyP. S.et al. (2015). Mitochondrial reticulum for cellular energy distribution in muscle. Nature523, 617–620. 10.1038/nature14614
57
HalestrapA. P.DavidsonA. M. (1990). Inhibition of Ca2+-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J.268, 153–160. 10.1042/bj2680153
58
HaworthR. A.HunterD. R. (1979). The Ca2+-induced membrane transition in mitochondria. II. Nature of the Ca2+ trigger site. Arch. Biochem. Biophys.195, 460–467. 10.1016/0003-9861(79)90372-2
59
HeJ.CarrollJ.DingS.FearnleyI. M.WalkerJ. E. (2017a). Permeability transition in human mitochondria persists in the absence of peripheral stalk subunits of ATP synthase. Proc. Natl. Acad. Sci. U.S.A.114, 9086–9091. 10.1073/pnas.1711201114
60
HeJ.FordH. C.CarrollJ.DingS.FearnleyI. M.WalkerJ. E. (2017b). Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase. Proc. Natl. Acad. Sci. U.S.A.114, 3409–3414. 10.1073/pnas.1702357114
61
HeideM.HaffnerC.MurayamaA.KurotakiY.ShinoharaH.OkanoH.et al. (2020). Human-specific ARHGAP11B increases size and folding of primate neocortex in the fetal marmoset. Science369, 546–550. 10.1126/science.abb2401
62
HerkenneS.EkO.ZamberlanM.PellattieroA.ChergovaM.ChiviteI.et al. (2020). Developmental and tumor angiogenesis requires the mitochondria-shaping protein Opa1. Cell Metab.31, 987–1003. 10.1016/j.cmet.2020.04.007
63
Hernansanz-AgustínP.Choya-FocesC.Carregal-RomeroS.RamosE.OlivaT.Villa-PiñaT.et al. (2020). Na+ controls hypoxic signalling by the mitochondrial respiratory chain. Nature586, 287–291. 10.1038/s41586-020-2551-y
64
HochF. L. (1962). Thyrotoxicosis as a disease of mitochondria. N. Engl. J. Med.266, 498–505. 10.1056/NEJM196203082661007
65
HunterD. R.HaworthR. A. (1979a). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys.195, 453–459. 10.1016/0003-9861(79)90371-0
66
HunterD. R.HaworthR. A. (1979b). The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch. Biochem. Biophys.195, 468–477. 10.1016/0003-9861(79)90373-4
67
HunterF. EJr.FordL. (1955). Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions. J. Biol. Chem.216, 357–369. 10.1016/S0021-9258(19)52312-2
68
ImbertiR.NieminenA. L.HermanB.LemastersJ. J. (1993). Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine. J. Pharmacol. Exp. Ther.265, 392–400.
69
InoueI.NagaseH.KishiK.HigutiT. (1991). ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature352, 244–247. 10.1038/352244a0
70
JainI. H.CalvoS. E.MarkhardA. L.SkinnerO. S.ToT. L.AstT.et al. (2020). Genetic screen for cell fitness in high or low oxygen highlights mitochondrial and lipid metabolism. Cell181, 716–727. 10.1016/j.cell.2020.03.029
71
JainI. H.ZazzeronL.GoldbergerO.MarutaniE.WojtkiewiczG. R.AstT.et al. (2019). Leigh syndrome mouse model can be rescued by interventions that normalize brain hyperoxia, but not HIF activation. Cell Metab.30, 824–832. 10.1016/j.cmet.2019.07.006
72
JainI. H.ZazzeronL.GoliR.AlexaK.Schatzman-BoneS.DhillonH.et al. (2016). Hypoxia as a therapy for mitochondrial disease. Science352, 54–61. 10.1126/science.aad9642
73
JenningsR. B.HerdsonP. B.SommersH. M. (1969). Structural and functional abnormalities in mitochondria isolated from ischemic dog myocardium. Lab. Invest.20, 548–557.
74
JikoC.DaviesK. M.Shinzawa-ItohK.TaniK.MaedaS.MillsD. J.et al. (2015). Bovine F1Fo ATP synthase monomers bend the lipid bilayer in 2D membrane crystals. eLife Sci.4:e06119. 10.7554/eLife.06119.022
75
KamerK. J.MoothaV. K. (2014). MICU1 and MICU2 play nonredundant roles in the regulation of the mitochondrial calcium uniporter. EMBO Rep.15, 299–307. 10.1002/embr.201337946
76
KampjutD.SazanovL. A. (2020). The coupling mechanism of mammalian respiratory complex I. Science370:547. 10.1126/science.abc4209
77
KarchJ.KwongJ. Q.BurrA. R.SargentM. A.ElrodJ. W.PeixotoP. M.et al. (2013). Bax and bak function as the outer membrane component of the mitochondrial permeability pore in regulating necrotic cell death in mice. eLife Sci.2:e00772. 10.7554/eLife.00772.020
78
KasbekarD. K.SreenivasanA. (1956). Lability of intramitochondrial components in experimental liver injury. Nature178, 989–990. 10.1038/178989b0
79
KlingenbergM. (1979). The ADP,ATP shuttle of the mitochondrion. Trends Biochem. Sci.4, 249–252. 10.1016/0968-0004(79)90215-9
80
KozakiT.KomanoJ.KanbayashiD.TakahamaM.MisawaT.SatohT.et al. (2017). Mitochondrial damage elicits a TCDD-inducible poly(ADP-ribose) polymerase-mediated antiviral response. Proc. Natl. Acad. Sci. U.S.A.114, 2681–2686. 10.1073/pnas.1621508114
81
KühlbrandtW. (2019). Structure and mechanisms of F-type ATP synthases. Annu. Rev. Biochem.88, 515–549. 10.1146/annurev-biochem-013118-110903
82
Lapuente-BrunE.Moreno-LoshuertosR.Acín-PérezR.Latorre-PellicerA.ColásC.BalsaE.et al. (2013). Supercomplex assembly determines electron flux in the mitochondrial electron transport chain. Science340, 1567–1570. 10.1126/science.1230381
83
LazarouM.SliterD. A.KaneL. A.SarrafS. A.WangC.BurmanJ. L.et al. (2015). The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature524, 309–314. 10.1038/nature14893
84
LettsJ. A.FiedorczukK.SazanovL. A. (2016). The architecture of respiratory supercomplexes. Nature537, 644–648. 10.1038/nature19774
85
LiuX.KimC. N.YangJ.JemmersonR.WangX. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell86, 147–157. 10.1016/S0092-8674(00)80085-9
86
Lobo-JarneT.NývltováE.Pérez-PérezR.Timón-GómezA.MoliniéT.ChoiA.et al. (2018). Human COX7A2L Regulates complex III biogenesis and promotes supercomplex organization remodeling without affecting mitochondrial bioenergetics. Cell Rep.25, 1786–1799. 10.1016/j.celrep.2018.10.058
87
LoganC. V.SzabadkaiG.SharpeJ. A.ParryD. A.TorelliS.ChildsA. M.et al. (2014). Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling. Nat. Genet.46, 188–193. 10.1038/ng.2851
88
LuftR.IkkosD.PalmieriG.ErnsterL.AfzeliusB. (1962). A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study. J. Clin. Invest.41, 1776–1804. 10.1172/JCI104637
89
MallilankaramanK.CardenasC.DoonanP. J.ChandramoorthyH. C.IrrinkiK. M.GolenarT.et al. (2012). MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. Nat. Cell Biol.15:123. 10.1038/ncb2669
90
MammucariC.RaffaelloA.Vecellio ReaneD.RizzutoR. (2016). Molecular structure and pathophysiological roles of the mitochondrial calcium uniporter. Biochim. Biophys. Acta1863, 2457–2464. 10.1016/j.bbamcr.2016.03.006
91
MarchettiP.CastedoM.SusinS. A.ZamzamiN.HirschT.MachoA.et al. (1996). Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med.184, 1155–1160. 10.1084/jem.184.3.1155
92
MassariS.AzzoneG. F. (1972). The equivalent pore radius of intact and damaged mitochondria and the mechanism of active shrinkage. Biochim. Biophys. Acta283, 23–29. 10.1016/0005-2728(72)90094-1
93
MatheoudD.SugiuraA.Bellemare-PelletierA.LaplanteA.RondeauC.ChemaliM.et al. (2016). Parkinson's disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation. Cell166, 314–327. 10.1016/j.cell.2016.05.039
94
MichelH.BehrJ.HarrengaA.KanntA. (1998). Cytochrome c oxidase: structure and spectroscopy. Annu. Rev. Biophys. Biomol. Struct.27, 329–356. 10.1146/annurev.biophys.27.1.329
95
MilanesiE.CostantiniP.GambalungaA.ColonnaR.PetronilliV.CabrelleA.et al. (2006). The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative. J. Biol. Chem.281, 10066–10072. 10.1074/jbc.M513708200
96
MilenkovicD.BlazaJ. N.LarssonN. G.HirstJ. (2017). The enigma of the respiratory chain supercomplex. Cell Metab.25, 765–776. 10.1016/j.cmet.2017.03.009
97
MillsE. L.KellyB.LoganA.CostaA. S. H.VarmaM.BryantC. E.et al. (2016). Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell167, 457–470. 10.1016/j.cell.2016.08.064
98
MishraP.ChanD. C. (2016). Metabolic regulation of mitochondrial dynamics. J. Cell Biol.212, 379–387. 10.1083/jcb.201511036
99
MitchellP. (1966). Chemiosmotic Coupling in Oxidative and Photosynthetic Phosphorylation. Bodmin: Glynn Research. 10.1111/j.1469-185X.1966.tb01501.x
100
MitchellP. (2011). Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. 1966. Biochim. Biophys. Acta1807, 1507–1538. 10.1016/j.bbabio.2011.09.018
101
MitchellP.MoyleJ. (1969). Translocation of some anions cations and acids in rat liver mitochondria. Eur. J. Biochem.9, 149–155. 10.1111/j.1432-1033.1969.tb00588.x
102
MnatsakanyanN.LlagunoM. C.YangY.YanY.WeberJ.SigworthF. J.et al. (2019). A mitochondrial megachannel resides in monomeric F1FO ATP synthase. Nat. Commun.10:5823. 10.1038/s41467-019-13766-2
103
MourierA.MaticS.RuzzenenteB.LarssonN. G.MilenkovicD. (2014). The respiratory chain supercomplex organization is independent of COX7a2l isoforms. Cell Metab.20, 1069–1075. 10.1016/j.cmet.2014.11.005
104
NambaT.DocziJ.PinsonA.XingL.KalebicN.Wilsch-BrauningerM.et al. (2020). Human-specific ARHGAP11B acts in mitochondria to expand neocortical progenitors by glutaminolysis. Neuron105, 867–881. 10.1016/j.neuron.2019.11.027
105
NichollsD. G. (1976). Hamster brown-adipose-tissue mitochondria. Purine nucleotide control of the ion conductance of the inner membrane, the nature of the nucleotide binding site. Eur. J. Biochem. 62, 223–228. 10.1111/j.1432-1033.1976.tb10151.x
106
NicolliA.BassoE.PetronilliV.WengerR. M.BernardiP. (1996). Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem.271, 2185–2192. 10.1074/jbc.271.4.2185
107
NirodyJ. A.BudinI.RangamaniP. (2020). ATP synthase: evolution, energetics, and membrane interactions. J. Gen. Physiol.152:e201912475. 10.1085/jgp.201912475
108
NobregaF. G.NobregaM. P.TzagoloffA. (1992). BCS1, a novel gene required for the expression of functional Rieske iron-sulfur protein in Saccharomyces cerevisiae. EMBO J.11, 3821–3829. 10.1002/j.1460-2075.1992.tb05474.x
109
NowikovskyK.BernardiP. (2014). LETM1 in mitochondrial cation transport. Front. Physiol.5:83. 10.3389/fphys.2014.00083
110
NowikovskyK.FroschauerE. M.ZsurkaG.SamajJ.ReipertS.KolisekM.et al. (2004). The LETM1/YOL027 gene family encodes a factor of the mitochondrial K+ homeostasis with a potential role in the wolf-hirschhorn syndrome. J. Biol. Chem.279, 30307–30315. 10.1074/jbc.M403607200
111
NowikovskyK.ReipertS.DevenishR. J.SchweyenR. J. (2007). Mdm38 protein depletion causes loss of mitochondrial K+/H+ exchange activity, osmotic swelling and mitophagy. Cell Death Differ.14, 1647–1656. 10.1038/sj.cdd.4402167
112
OkaT.HikosoS.YamaguchiO.TaneikeM.TakedaT.TamaiT.et al. (2012). Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature485, 251–255. 10.1038/nature10992
113
OkoyeI.WangL.PallmerK.RichterK.IchimuraT.HaasR.et al. (2015). T cell metabolism. The protein LEM promotes CD8+ T cell immunity through effects on mitochondrial respiration. Science348, 995–1001. 10.1126/science.aaa7516
114
OltersdorfT.ElmoreS. W.ShoemakerA. R.ArmstrongR. C.AugeriD. J.BelliB. A.et al. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature435, 677–681. 10.1038/nature03579
115
OsteryoungK. W.NunnariJ. (2003). The division of endosymbiotic organelles. Science302, 1698–1704. 10.1126/science.1082192
116
OstojicJ.PanozzoC.LasserreJ. P.NouetC.CourtinF.BlancardC.et al. (2013). The energetic state of mitochondria modulates complex III biogenesis through the ATP-dependent activity of Bcs1. Cell Metab.18, 567–577. 10.1016/j.cmet.2013.08.017
117
PaggioA.ChecchettoV.CampoA.MenabòR.Di MarcoG.Di LisaF.et al. (2019). Identification of an ATP-sensitive potassium channel in mitochondria. Nature572, 609–613. 10.1038/s41586-019-1498-3
118
PalmieriF.MonnéM. (2016). Discoveries, metabolic roles and diseases of mitochondrial carriers: a review. Biochim. Biophys. Acta1863, 2362–2378. 10.1016/j.bbamcr.2016.03.007
119
PastorinoJ. G.SnyderJ. W.SerroniA.HoekJ. B.FarberJ. L. (1993). Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem.268, 13791–13798. 10.1016/S0021-9258(19)85172-4
120
PaumardP.VaillierJ.CoularyB.SchaefferJ.SoubannierV.MuellerD. M.et al. (2002). The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J.21, 221–230. 10.1093/emboj/21.3.221
121
PernasL.BeanC.BoothroydJ. C.ScorranoL. (2018). Mitochondria restrict growth of the intracellular parasite Toxoplasma gondii by limiting its uptake of fatty acids. Cell Metab.27, 886–897. 10.1016/j.cmet.2018.02.018
122
PerocchiF.GohilV. M.GirgisH. S.BaoX. R.McCombsJ. E.PalmerA. E.et al. (2010). MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake. Nature467, 291–296. 10.1038/nature09358
123
PetronilliV.NicolliA.CostantiniP.ColonnaR.BernardiP. (1994). Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta1187, 255–259. 10.1016/0005-2728(94)90122-8
124
PfeifferD. R.SchmidP. C.BeatriceM. C.SchmidH. H. (1979). Intramitochondrial phospholipase activity and the effects of Ca2+ plus N-ethylmaleimide on mitochondrial function. J. Biol. Chem.254, 11485–11494. 10.1016/S0021-9258(19)86511-0
125
PinkeG.ZhouL.SazanovL. A. (2020). Cryo-EM structure of the entire mammalian F-type ATP synthase. Nat. Struct. Mol. Biol.27, 1077–1085. 10.1038/s41594-020-0503-8
126
ProtasoniM.Pérez-PérezR.Lobo-JarneT.HarbourM. E.DingS.PeñasA.et al. (2020). Respiratory supercomplexes act as a platform for complex III-mediated maturation of human mitochondrial complexes I and IV. EMBO J.39, e102817. 10.15252/embj.2019102817
127
RafaelJ.HeldtH. W. (1976). Binding of guanine nucleotides to the outer surface of the inner membrane of guinea pig brown fat mitochondria in correlation with the thermogenic activity of the tissue. FEBS Lett.63, 304–308. 10.1016/0014-5793(76)80117-2
128
RathS.SharmaR.GuptaR.AstT.ChanC.DurhamT. J.et al. (2020). MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res.49, D1541–D1547. 10.1093/nar/gkaa1011
129
RathoreS.BerndtssonJ.Marin-BueraL.ConradJ.CarroniM.BrzezinskiP.et al. (2019). Cryo-EM structure of the yeast respiratory supercomplex. Nat. Struct. Mol. Biol.26, 50–57. 10.1038/s41594-018-0169-7
130
RizzutoR.BriniM.MurgiaM.PozzanT. (1993). Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science262, 744–747. 10.1126/science.8235595
131
Rodríguez-NuevoA.Díaz-RamosA.NogueraE.Díaz-SáezF.DuranX.MuñozJ. P.et al. (2018). Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. EMBO J.37:e96553. 10.15252/embj.201796553
132
RuprechtJ. J.HellawellA. M.HardingM.CrichtonP. G.McCoyA. J.KunjiE. R. (2014). Structures of yeast mitochondrial ADP/ATP carriers support a domain-based alternating-access transport mechanism. Proc. Natl. Acad. Sci. U.S.A.111, E426–E434. 10.1073/pnas.1320692111
133
RuprechtJ. J.KingM. S.ZoggT.AleksandrovaA. A.PardonE.CrichtonP. G.et al. (2019). The molecular mechanism of transport by the mitochondrial ADP/ATP carrier. Cell176, 435–447. 10.1016/j.cell.2018.11.025
134
SamantaD.SemenzaG. L. (2018). Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochim. Biophys. Acta Rev. Cancer1870, 15–22. 10.1016/j.bbcan.2018.07.002
135
SancakY.MarkhardA. L.KitamiT.Kovacs-BogdanE.KamerK. J.UdeshiN. D.et al. (2013). EMRE is an essential component of the mitochondrial calcium uniporter complex. Science342, 1379–1382. 10.1126/science.1242993
136
SchäggerH.PfeifferK. (2000). Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J.19, 1777–1783. 10.1093/emboj/19.8.1777
137
SchäggerH.PfeifferK. (2001). The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J. Biol. Chem.276, 37861–37867. 10.1074/jbc.M106474200
138
SciacovelliM.GuzzoG.MorelloV.FrezzaC.ZhengL.NanniniN.et al. (2013). The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab.17, 988–999. 10.1016/j.cmet.2013.04.019
139
ScorranoL.AshiyaM.ButtleK.WeilerS.OakesS. A.MannellaC. A.et al. (2002). A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell2, 55–67. 10.1016/S1534-5807(01)00116-2
140
SelakM. A.ArmourS. M.MacKenzieE. D.BoulahbelH.WatsonD. G.MansfieldK. D.et al. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell7, 77–85. 10.1016/j.ccr.2004.11.022
141
ShintaniY.DrexlerH. C.KiokaH.TerraccianoC. M.CoppenS. R.ImamuraH.et al. (2014). Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2. EMBO Rep.15, 438–445. 10.1002/embr.201337945
142
SholtzK. F.GorskayaI. A.KotelnikovaA. V. (1983). The stoichiometry of proton translocation through H+-ATPase of rat-liver mitochondria. Eur. J. Biochem.136, 129–134. 10.1111/j.1432-1033.1983.tb07715.x
143
SingerT. P.CastagnoliN.Jr.RamsayR. R.TrevorA. J. (1987). Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Neurochem.49, 1–8. 10.1111/j.1471-4159.1987.tb03384.x
144
SinghR.LetaiA.SarosiekK. (2019). Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell. Biol.20, 175–193. 10.1038/s41580-018-0089-8
145
SliterD. A.MartinezJ.HaoL.ChenX.SunN.FischerT. D.et al. (2018). Parkin and PINK1 mitigate STING-induced inflammation. Nature561, 258–262. 10.1038/s41586-018-0448-9
146
SmithP. M.FoxJ. L.WingeD. R. (2012). Biogenesis of the cytochrome bc1 complex and role of assembly factors. Biochim. Biophys. Acta1817, 276–286. 10.1016/j.bbabio.2011.11.009
147
SouersA. J.LeversonJ. D.BoghaertE. R.AcklerS. L.CatronN. D.ChenJ.et al. (2013). ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med.19, 202–208. 10.1038/nm.3048
148
SpikesT. E.MontgomeryM. G.WalkerJ. E. (2021). Interface mobility between monomers in dimeric bovine ATP synthase participates in the ultrastructure of inner mitochondrial membranes. Proc. Natl. Acad. Sci. U.S.A.118:e2021012118. 10.1073/pnas.2021012118
149
SternliebI. (1968). Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology55, 354–367. 10.1016/S0016-5085(19)34045-4
150
StonerC. D. (1984). Steady-state kinetics of the overall oxidative phosphorylation reaction in heart mitochondria. Determination of the coupling relationships between the respiratory reactions and miscellaneous observations concerning rate-limiting steps. J. Bioenerg. Biomembr. 16, 115–141. 10.1007/BF00743044
151
SusinS. A.ZamzamiN.CastedoM.HirschT.MarchettiP.MachoA.et al. (1996). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med.184, 1331–1341. 10.1084/jem.184.4.1331
152
SzabóI.ZorattiM. (2014). Mitochondrial channels: ion fluxes and more. Physiol. Rev.94, 519–608. 10.1152/physrev.00021.2013
153
SzewczykA.SkalskaJ.GlabM.KlawiakB.MalinskaD.Koszela-PiotrowskaI.et al. (2006). Mitochondrial potassium channels: from pharmacology to function. Biochim. Biophys. Acta1757, 715–720. 10.1016/j.bbabio.2006.05.002
154
ToT. L.CuadrosA. M.ShahH.HungW. H. W.LiY.KimS. H.et al. (2019). A compendium of genetic modifiers of mitochondrial dysfunction reveals intra-organelle buffering. Cell179, 1222–1238. 10.1016/j.cell.2019.10.032
155
TsaiM. F.JiangD.ZhaoL.ClaphamD.MillerC. (2014). Functional reconstitution of the mitochondrial Ca2+/H+ antiporter Letm1. J. Gen. Physiol.143, 67–73. 10.1085/jgp.201311096
156
TsukiharaT.AoyamaH.YamashitaE.TomizakiT.YamaguchiH.Shinzawa-ItohK.et al. (1996). The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 Å. Science272, 1136–1144. 10.1126/science.272.5265.1136
157
TwigG.ElorzaA.MolinaA. J.MohamedH.WikstromJ. D.WalzerG.et al. (2008). Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J.27, 433–446. 10.1038/sj.emboj.7601963
158
UrbaniA.GiorgioV.CarrerA.FranchinC.ArrigoniG.JikoC.et al. (2019). Purified F-ATP synthase forms a Ca2+-dependent high-conductance channel matching the mitochondrial permeability transition pore. Nat. Commun.10:4341. 10.1038/s41467-019-12331-1
159
VaillierJ.ArselinG.GravesP. V.CamougrandN.VeloursJ. (1999). Isolation of supernumerary yeast ATP synthase subunits e and i. Characterization of subunit i and disruption of its structural gene ATP18. J. Biol. Chem.274, 543–548. 10.1074/jbc.274.1.543
160
van WijngaardeenG. K.BethlemJ.MeijerA. E.HulsmannW. C.FeltkampC. A. (1967). Skeletal muscle disease with abnormal mitochondria. Brain90, 577–592. 10.1093/brain/90.3.577
161
WallaceD. C. (2007). Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu. Rev. Biochem.76, 781–821. 10.1146/annurev.biochem.76.081205.150955
162
WallaceD. C.SinghG.LottM. T.HodgeJ. A.SchurrT. G.LezzaA. M.et al. (1988). Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science242, 1427–1430. 10.1126/science.3201231
163
WarburgO. (1956). On the origin of cancer cells. Science123, 309–314. 10.1126/science.123.3191.309
164
WarburgO.WindF.NegeleinE. (1927). The metabolism of tumors in the body. J. Gen. Physiol.8, 519–530. 10.1085/jgp.8.6.519
165
WeiM. C.LindstenT.MoothaV. K.WeilerS.GrossA.AshiyaM.et al. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev.14, 2060–2071. 10.1101/gad.14.16.2060
166
WeiW.TunaS.KeoghM. J.SmithK. R.AitmanT. J.BealesP. L.et al. (2019). Germline selection shapes human mitochondrial DNA diversity. Science364:eaau6520. 10.1126/science.aau6520
167
WeinbergS. E.SingerB. D.SteinertE. M.MartinezC. A.MehtaM. M.Martínez-ReyesI.et al. (2019). Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature565, 495–499. 10.1038/s41586-018-0846-z
168
WesterhoffH. V.Van der BendR. L.van DamK.BerdenJ.PetersonJ. (1986). A model system for delocalized chemiosmotic coupling exhibited the features thought diagnostic of localized coupling. Biochem. J.236, 932–933. 10.1042/bj2360932
169
WolfD. M.SegawaM.KondadiA. K.AnandR.BaileyS. T.ReichertA. S.et al. (2019). Individual cristae within the same mitochondrion display different membrane potentials and are functionally independent. EMBO J.38:e101056. 10.15252/embj.2018101056
170
WollenbergerA.KleitkeB.RaabeG. (1963). Some metabolic characteristics of mitochondria from chronically overloaded, hypertrophied hearts. Exp. Mol. Pathol.2, 251–260. 10.1016/0014-4800(63)90040-6
171
WrogemannK.PenaS. D. (1976). Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet1, 672–674. 10.1016/S0140-6736(76)92781-1
172
XiaD.YuC. A.KimH.XiaJ. Z.KachurinA. M.ZhangL.et al. (1997). Crystal structure of the cytochrome bc1 complex from bovine heart mitochondria. Science277, 60–66. 10.1126/science.277.5322.60
173
YaguzhinskyL. S.YurkovV. I.KrasinskayaI. P. (2006). On the localized coupling of respiration and phosphorylation in mitochondria. Biochim. Biophys. Acta1757, 408–414. 10.1016/j.bbabio.2006.04.001
174
YangJ.LiuX.BhallaK.KimC. N.IbradoA. M.CaiJ.et al. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science275, 1129–1132. 10.1126/science.275.5303.1129
175
YuC. H.DavidsonS.HarapasC. R.HiltonJ. B.MlodzianoskiM. J.LaohamonthonkulP.et al. (2020). TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell183, 636–649. 10.1016/j.cell.2020.09.020
176
ZhangQ.RaoofM.ChenY.SumiY.SursalT.JungerW.et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature464, 104–107. 10.1038/nature08780
177
ZhaoQ.LiuJ.DengH.MaR.LiaoJ. Y.LiangH.et al. (2020). Targeting mitochondria-located circRNA SCAR Alleviates NASH via reducing mROS output. Cell183, 76–93. 10.1016/j.cell.2020.08.009
178
ZhongZ.LiangS.Sanchez-LopezE.HeF.ShalapourS.LinX. J.et al. (2018). New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature560, 198–203. 10.1038/s41586-018-0372-z
179
ZhouR.YazdiA. S.MenuP.TschoppJ. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature469, 221–225. 10.1038/nature09663
180
ZickermannV.WirthC.NasiriH.SiegmundK.SchwalbeH.HunteC.et al. (2015). Structural biology. Mechanistic insight from the crystal structure of mitochondrial complex I. Science347, 44–49. 10.1126/science.1259859
Summary
Keywords
mitochondria, ATP synthase, channels, pathophysiology, hypoxia
Citation
Bernardi P (2021) Looking Back to the Future of Mitochondrial Research. Front. Physiol. 12:682467. doi: 10.3389/fphys.2021.682467
Received
18 March 2021
Accepted
12 April 2021
Published
30 April 2021
Volume
12 - 2021
Edited by
George E. Billman, The Ohio State University, United States
Reviewed by
David Sebastián, Institute for Research in Biomedicine, Spain
Updates
Copyright
© 2021 Bernardi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paolo Bernardi paolo.bernardi@unipd.it
This article was submitted to Mitochondrial Research, a section of the journal Frontiers in Physiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.